Virologica Sinica

, Volume 31, Issue 6, pp 472–479 | Cite as

The role of microRNAs in hepatocyte metabolism and hepatitis B virus replication

Review

Abstract

Though efficient vaccines against hepatitis B virus (HBV) and antiviral therapies are available, chronic HBV infection is still a global health problem. The process of HBV infection and HBV life cycle are extensively studied in last decades, however, the mechanisms of HBV-induced alterations of host cell metabolisms and host factors involved in modulating of viral replication are not fully understood. Thus, it is an important issue to examine these specific HBV-host interactions for development of novel strategies for antiviral therapies. Recently, microRNAs (miRNAs), a class of post-transcriptional regulatory small RNA, seem to be the relevant fine tuning factors of various cellular activities and pathways, including cell growth, metabolism, and viral replication. In this review, we summarize the up to date knowledge concerning the virus-host interactions and emphasizing on the role of miRNAs in regulation of HBV replication and host cell metabolism.

Keywords

microRNA HBV replication hepatocytes cell metabolism transcription factors 

References

  1. Bar-Yishay I, Shaul Y, Shlomai A. 2011. Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression. Liver Int, 31: 282–290.CrossRefPubMedGoogle Scholar
  2. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell, 116: 281–297.CrossRefPubMedGoogle Scholar
  3. Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A, Tang H. 2015. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331–3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. Oncotarget, 6: 38093–38106.PubMedPubMedCentralGoogle Scholar
  4. Chen C, Wu M, Zhang W, Lu W, Zhang M, Zhang Z, Zhang X, Yuan Z. 2016. MicroRNA-939 restricts Hepatitis B virus by targeting Jmjd3-mediated and C/EBPalpha-coordinated chromatin remodeling. Sci Rep, 6: 35974.CrossRefPubMedPubMedCentralGoogle Scholar
  5. Chu R, Mo G, Duan Z, Huang M, Chang J, Li X, Liu P. 2014. miRNAs affect the development of hepatocellular carcinoma via dysregulation of their biogenesis and expression. Cell Commun Signal, 12: 45CrossRefPubMedPubMedCentralGoogle Scholar
  6. Cui M, Wang Y, Sun BD, Xiao ZL, Ye LH, Zhang XD. 2014. MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA. Biochem Bioph Res Co, 444: 270–275.CrossRefGoogle Scholar
  7. Dai X, Zhang W, Zhang H, Sun S, Yu H, Guo Y, Kou Z, Zhao G, Du L, Jiang S, Zhang J, Li J, Zhou Y. 2014. Modulation of HBV replication by microRNA-15b through targeting hepatocyte nuclear factor 1alpha. Nucleic Acids Res, 42: 6578–6590.CrossRefPubMedPubMedCentralGoogle Scholar
  8. Damania P, Sen B, Dar SB, Kumar S, Kumari A, Gupta E, Sarin SK, Venugopal SK. 2014. Hepatitis B virus induces cell proliferation via HBx-induced microRNA-21 in hepatocellular carcinoma by targeting programmed cell death protein4 (PDCD4) and phosphatase and tensin homologue (PTEN). PLoS One, 9: e91745.CrossRefPubMedPubMedCentralGoogle Scholar
  9. Davalos A, Goedeke L, Smibert P, Ramirez CM, Warrier NP, Andreo U, Cirera-Salinas D, Rayner K, Suresh U, Pastor-Pareja JC, Esplugues E, Fisher EA, Penalva LO, Moore KJ, Suarez Y, Lai EC, Fernandez-Hernando C. 2011. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci U S A, 108: 9232–9237.CrossRefPubMedPubMedCentralGoogle Scholar
  10. Dluzen DF, Sun D, Salzberg AC, Jones N, Bushey RT, Robertson GP, Lazarus P. 2014. Regulation of UDP-glucuronosyltransferase 1A1 expression and activity by microRNA 491–3p. J Pharmacol Exp Ther, 348: 465–477.CrossRefPubMedPubMedCentralGoogle Scholar
  11. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R, Subramaniam A, Propp S, Lollo BA, Freier S, Bennett CF, Bhanot S, Monia BP. 2006. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab, 3: 87–98.CrossRefPubMedGoogle Scholar
  12. Fan CG, Wang CM, Tian C, Wang Y, Li L, Sun WS, Li RF, Liu YG. 2011. miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3. Oncol Rep, 26: 1281–1286.PubMedGoogle Scholar
  13. Fan H, Lv P, Lv J, Zhao X, Liu M, Zhang G, Tang H. 2016. miR-370 suppresses HBV gene expression and replication by targeting nuclear factor IA. J Med Virol. doi: 10.1002/jmv.24695.Google Scholar
  14. Gao F, Sun X, Wang L, Tang S, Yan C. 2015. Downregulation of MicroRNA-145 Caused by Hepatitis B Virus X Protein Promotes Expression of CUL5 and Contributes to Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma. Cell Physiol Biochem, 37: 1547–1559.CrossRefPubMedGoogle Scholar
  15. Gerin I, Bommer GT, McCoin CS, Sousa KM, Krishnan V, Mac-Dougald OA. 2010. Roles for miRNA-378/378* in adipocyte gene expression and lipogenesis. Am J Physiol Endocrinol Metab, 299: E198–E206.PubMedPubMedCentralGoogle Scholar
  16. Grimm D, Thimme R, Blum HE. 2011. HBV life cycle and novel drug targets. Hepatol Int, 5: 644–653.CrossRefPubMedPubMedCentralGoogle Scholar
  17. Guo H, Liu H, Mitchelson K, Rao H, Luo M, Xie L, Sun Y, Zhang L, Lu Y, Liu R, Ren A, Liu S, Zhou S, Zhu J, Zhou Y, Huang A, Wei L, Guo Y, Cheng J. 2011. MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B. Hepatology, 54: 808–819.CrossRefPubMedGoogle Scholar
  18. Guo W, Qiu Z, Wang Z, Wang Q, Tan N, Chen T, Chen Z, Huang S, Gu J, Li J, Yao M, Zhao Y, He X. 2015. MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer. Hepatology, 62: 1132–1144.CrossRefPubMedGoogle Scholar
  19. Hammond SM. 2015. An overview of microRNAs. Adv Drug Deliv Rev, 87: 3–14.CrossRefPubMedPubMedCentralGoogle Scholar
  20. Hao R, He J, Liu X, Gao G, Liu D, Cui L, Yu G, Yu W, Chen Y, Guo D. 2015. Inhibition of hepatitis B virus gene expression and replication by hepatocyte nuclear factor 6. J Virol, 89: 4345–4355.CrossRefPubMedPubMedCentralGoogle Scholar
  21. Hoekstra M, van der Sluis RJ, Kuiper J, Van Berkel TJ. 2012. Nonalcoholic fatty liver disease is associated with an altered hepatocyte microRNA profile in LDL receptor knockout mice. J Nutr Biochem, 23: 622–628.CrossRefPubMedGoogle Scholar
  22. Hsu PP, Sabatini DM. 2008. Cancer cell metabolism: Warburg and beyond. Cell, 134: 703–707.CrossRefPubMedGoogle Scholar
  23. Hu W, Wang X, Ding X, Li Y, Zhang X, Xie P, Yang J, Wang S. MicroRNA-141 represses HBV replication by targeting PPARA. PLoS One. 2012; 7: e34165.CrossRefPubMedPubMedCentralGoogle Scholar
  24. Huang JY, Chen HL, Shih C. 2016. MicroRNA miR-204 and miR-1236 inhibit hepatitis B virus replication via two different mechanisms. Sci Rep, 6: 34740.CrossRefPubMedPubMedCentralGoogle Scholar
  25. Huang JY, Chou SF, Lee JW, Chen HL, Chen CM, Tao MH, Shih C. 2015. MicroRNA-130a can inhibit hepatitis B virus replication via targeting PGC1alpha and PPARgamma. RNA, 21: 385–400.CrossRefPubMedPubMedCentralGoogle Scholar
  26. Hung JH, Yan CW, Su IJ, Wang HC, Lei HY, Lin WC, Chang WT, Huang W, Lu TJ, Lai MD. 2010. Hepatitis B virus surface antigen interacts with acid alpha-glucosidase and alters glycogen metabolism. Hepatol Res, 40: 633–640.CrossRefPubMedGoogle Scholar
  27. Hung TM, Ho CM, Liu YC, Lee JL, Liao YR, Wu YM, Ho MC, Chen CH, Lai HS, Lee PH. 2014. Up-regulation of microRNA-190b plays a role for decreased IGF-1 that induces insulin resistance in human hepatocellular carcinoma. PLoS One, 9: e89446.CrossRefPubMedPubMedCentralGoogle Scholar
  28. Iavarone M, Colombo M. 2013. HBV infection and hepatocellular carcinoma. Clin Liver Dis, 17: 375–397.CrossRefPubMedGoogle Scholar
  29. Iliopoulos D, Drosatos K, Hiyama Y, Goldberg IJ, Zannis VI. 2010. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid Res, 51: 1513–1523.CrossRefPubMedPubMedCentralGoogle Scholar
  30. Jhuang HJ, Hsu WH, Lin KT, Hsu SL, Wang FS, Chou CK, Lee KH, Tsou AP, Lai JM, Yeh SF, Huang CYF. 2015. Gluconeogenesis, lipogenesis, and HBV replication are commonly regulated by PGC-1 alpha-dependent pathway. Oncotarget, 6: 7788–7803.CrossRefPubMedPubMedCentralGoogle Scholar
  31. Jiang JX, Gao S, Pan YZ, Yu C, Sun CY. 2014. Overexpression of microRNA-125b sensitizes human hepatocellular carcinoma cells to 5-fluorouracil through inhibition of glycolysis by targeting hexokinase II. Mol Med Rep, 10: 995–1002.PubMedGoogle Scholar
  32. Jordan SD, Kruger M, Willmes DM, Redemann N, Wunderlich FT, Bronneke HS, Merkwirth C, Kashkar H, Olkkonen VM, Bottger T, Braun T, Seibler J, Bruning JC. 2011. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat Cell Biol, 13: 434–446.CrossRefPubMedGoogle Scholar
  33. Khee SG, Yusof YA, Makpol S. 2014. Expression of senescenceassociated microRNAs and target genes in cellular aging and modulation by tocotrienol-rich fraction. Oxid Med Cell Longev, 2014: 725929.PubMedGoogle Scholar
  34. Kim HY, Cho HK, Kim HH, Cheong J. 2011. Oxygenated derivatives of cholesterol promote hepatitis B virus gene expression through nuclear receptor LXR alpha activation. Virus Research, 158: 55–61.CrossRefPubMedGoogle Scholar
  35. Kim J, Yoon H, Ramirez CM, Lee SM, Hoe HS, Fernandez-Hernando C. 2012. MiR-106b impairs cholesterol efflux and increases Abeta levels by repressing ABCA1 expression. Exp Neurol, 235: 476–483.CrossRefPubMedGoogle Scholar
  36. Kim KH, Shin HJ, Kim K, Choi HM, Rhee SH, Moon HB, Kim HH, Yang US, Yu DY, Cheong J. 2007. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma. Gastroenterology, 132: 1955–1967.CrossRefPubMedGoogle Scholar
  37. Kornfeld JW, Baitzel C, Konner AC, Nicholls HT, Vogt MC, Herrmanns K, Scheja L, Haumaitre C, Wolf AM, Knippschild U, Seibler J, Cereghini S, Heeren J, Stoffel M, Bruning JC. 2013. Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b. Nature, 494: 111–115.CrossRefPubMedGoogle Scholar
  38. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. 2005. Silencing of microRNAs in vivo with ‘antagomirs’. Nature, 438: 685–689.CrossRefPubMedGoogle Scholar
  39. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. 2002. Identification of tissue-specific microRNAs from mouse. Curr Biol, 12: 735–739.CrossRefPubMedGoogle Scholar
  40. Li F, Zhou P, Deng W, Wang J, Mao R, Zhang Y, Li J, Yu J, Yang F, Huang Y, Lu M, Zhang J. Serum microRNA-125b correlates with hepatitis B viral replication and liver necroinflammation. Clin Microbiol Infect. 2016 Apr; 22: 384.PubMedGoogle Scholar
  41. Li H, Zhu W, Zhang L, Lei H, Wu X, Guo L, Chen X, Wang Y, Tang H. 2015a. The metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatment. Sci Rep, 5: 8421.CrossRefPubMedPubMedCentralGoogle Scholar
  42. Li K, Zhang J, Yu J, Liu B, Guo Y, Deng J, Chen S, Wang C, Guo F. 2015b. MicroRNA-214 suppresses gluconeogenesis by targeting activating transcriptional factor 4. J Biol Chem, 290: 8185–8195.CrossRefPubMedPubMedCentralGoogle Scholar
  43. Lin Y, Deng W, Pang J, Kemper T, Hu J, Yin J, Zhang J, Lu M. 2016. The microRNA-99 family modulates hepatitis B virus replication by promoting IGF-1R/PI3K/Akt/mTOR/ULK1 signaling-induced autophagy. Cell Microbiol. doi: 10.1111/cmi.12709.Google Scholar
  44. Liu AM, Xu Z, Shek FH, Wong KF, Lee NP, Poon RT, Chen J, Luk JM. 2014. miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma. PLoS One, 9: e86872.CrossRefPubMedPubMedCentralGoogle Scholar
  45. Liu WH, Yeh SH, Lu CC, Yu SL, Chen HY, Lin CY, Chen DS, Chen PJ. 2009. MicroRNA-18a prevents estrogen receptoralpha expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology, 136: 683–693.CrossRefPubMedGoogle Scholar
  46. Ma XY, Li CC, Sun LC, Huang D, Li TT, He XP, Wu GW, Yang Z, Zhong XY, Song LB, Gao P, Zhang HF. 2014. Lin28/let-7 axis regulates aerobic glycolysis and cancer progression via PDK1. Nat Commun, 5: 5212.CrossRefPubMedGoogle Scholar
  47. Mattis AN, Song G, Hitchner K, Kim RY, Lee AY, Sharma AD, Malato Y, McManus MT, Esau CC, Koller E, Koliwad S, Lim LP, Maher JJ, Raffai RL, Willenbring H. 2015. A screen in mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for lipid distribution away from the liver. Hepatology, 61: 141–152.CrossRefPubMedGoogle Scholar
  48. Mizuguchi Y, Takizawa T, Uchida E. 2015. Host cellular microRNA involvement in the control of hepatitis B virus gene expression and replication. World J Hepatol, 7: 696–702.CrossRefPubMedPubMedCentralGoogle Scholar
  49. Na TY, Shin YK, Roh KJ, Kang SA, Hong I, Oh SJ, Seong JK, Park CK, Choi YL, Lee M-O. 2009. Liver X Receptor Mediates Hepatitis B Virus X Protein-Induced Lipogenesis in Hepatitis B Virus-Associated Hepatocellular Carcinoma. Hepatology, 49: 1122–1131.CrossRefPubMedGoogle Scholar
  50. Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, Gerszten RE, Naar AM. 2010. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science, 328: 1566–1569.CrossRefPubMedGoogle Scholar
  51. Nakanishi N, Nakagawa Y, Tokushige N, Aoki N, Matsuzaka T, Ishii K, Yahagi N, Kobayashi K, Yatoh S, Takahashi A, Suzuki H, Urayama O, Yamada N, Shimano H. 2009. The up-regulation of microRNA-335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese mice. Biochem Biophys Res Commun, 385: 492–496.CrossRefPubMedGoogle Scholar
  52. Ng R, Wu H, Xiao H, Chen X, Willenbring H, Steer CJ, Song G. 2014. Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia. Hepatology, 60: 554–564.CrossRefPubMedPubMedCentralGoogle Scholar
  53. Oehler N, Volz T, Bhadra OD, Kah J, Allweiss L, Giersch K, Bierwolf J, Riecken K, Pollok JM, Lohse AW, Fehse B, Petersen J, Urban S, Luetgehetmann M, Heeren J, Dandri M. 2014. Binding of Hepatitis B Virus to Its Cellular Receptor Alters the Expression Profile of Genes of Bile Acid Metabolism. Hepatology, 60: 1483–1493.CrossRefPubMedGoogle Scholar
  54. Peng F, Xiao XQ, Jiang YF, Luo KZ, Tian Y, Peng ML, Zhang M, Xu Y, Gong GZ. 2014. HBx Down-Regulated Gld2 Plays a Critical Role in HBV-Related Dysregulation of miR-122. PLoS One, 9: e92998.CrossRefPubMedPubMedCentralGoogle Scholar
  55. Potenza N, Papa U, Mosca N, Zerbini F, Nobile V, Russo A. 2011. Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen. Nucleic Acids Res, 39: 5157–5163.CrossRefPubMedPubMedCentralGoogle Scholar
  56. Ramirez CM, Davalos A, Goedeke L, Salerno AG, Warrier N, Cirera-Salinas D, Suarez Y, Fernandez-Hernando C. 2011. MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler Thromb Vasc Biol, 31: 2707–2714.CrossRefPubMedPubMedCentralGoogle Scholar
  57. Rayner KJ, Esau CC, Hussain FN, McDaniel AL, Marshall SM, van Gils JM, Ray TD, Sheedy FJ, Goedeke L, Liu X, Khatsenko OG, Kaimal V, Lees CJ, Fernandez-Hernando C, Fisher EA, Temel RE, Moore KJ. 2011. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature, 478: 404–407.CrossRefPubMedPubMedCentralGoogle Scholar
  58. Rottiers V, Naar AM. 2012. MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol, 13: 239–250.CrossRefPubMedPubMedCentralGoogle Scholar
  59. Sarkar N, Panigrahi R, Pal A, Biswas A, Singh SP, Kar SK, Bandopadhyay M, Das D, Saha D, Kanda T, Sugiyama M, Chakrabarti S, Banerjee A, Chakravarty R. 2015. Expression of microRNA-155 correlates positively with the expression of Tolllike receptor 7 and modulates hepatitis B virus via C/EBP-beta in hepatocytes. J Viral Hepat, 22: 817–827.CrossRefPubMedGoogle Scholar
  60. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. 2015. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet, 386: 1546–1555.CrossRefPubMedGoogle Scholar
  61. Shi YX, Huang CJ, Yang ZG. 2016. Impact of hepatitis B virus infection on hepatic metabolic signaling pathway. World J Gastroenterol, 22: 8161–8167.CrossRefPubMedPubMedCentralGoogle Scholar
  62. Shirasaki T, Honda M, Shimakami T, Horii R, Yamashita T, Sakai Y, Sakai A, Okada H, Watanabe R, Murakami S, Yi M, Lemon SM, Kaneko S. 2013. MicroRNA-27a Regulates Lipid Metabolism and Inhibits Hepatitis C Virus Replication in Human Hepatoma Cells. Journal of Virology, 87: 5270–5286.CrossRefPubMedPubMedCentralGoogle Scholar
  63. Shyh-Chang N, Daley GQ. 2013. Lin28: primal regulator of growth and metabolism in stem cells. Cell Stem Cell, 12: 395–406.CrossRefPubMedPubMedCentralGoogle Scholar
  64. Sidhu K, Kapoor NR, Pandey V, Kumar V. 2015. The “Macro” World of microRNAs in Hepatocellular Carcinoma. Front Oncol, 5: 68.CrossRefPubMedPubMedCentralGoogle Scholar
  65. Teng CF, Hsieh WC, Wu HC, Lin YJ, Tsai HW, Huang W, Su IJ. 2015. Hepatitis B Virus Pre-S2 Mutant Induces Aerobic Glycolysis through Mammalian Target of Rapamycin Signal Cascade. PLoS One, 10: e0122373.CrossRefPubMedPubMedCentralGoogle Scholar
  66. Wang K, Holterman AX. 2012. Pathophysiologic role of hepatocyte nuclear factor 6. Cell Signal, 24: 9–16.CrossRefPubMedGoogle Scholar
  67. Wang Y, Jiang L, Ji X, Yang B, Zhang Y, Fu XD. 2013. Hepatitis B Viral RNA Directly Mediates Down-regulation of the Tumor Suppressor MicroRNA miR-15a/miR-16–1 in Hepatocytes. J Biol Chem, 288: 18484–18493.CrossRefPubMedPubMedCentralGoogle Scholar
  68. Wang Y, Lu Y, Toh ST, Sung WK, Tan P, Chow P, Chung AY, Jooi LL, Lee CG. 2010. Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. J Hepatol, 53: 57–66.CrossRefPubMedGoogle Scholar
  69. Wang Y, Wang CM, Jiang ZZ, Yu XJ, Fan CG, Xu FF, Zhang Q, Li LI, Li RF, Sun WS, Zhang ZH, Liu YG. 2015. MicroRNA-34c targets TGFB-induced factor homeobox 2, represses cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma. Oncol Lett, 10: 3095–3102.PubMedPubMedCentralGoogle Scholar
  70. Wei B, Song Y, Zhang Y, Hu M. 2013. microRNA-449a functions as a tumor-suppressor in gastric adenocarcinoma by targeting Bcl-2. Oncol Lett, 6: 1713–1718.PubMedPubMedCentralGoogle Scholar
  71. Winther TN, Bang-Berthelsen CH, Heiberg IL, Pociot F, Hogh B. 2013. Differential Plasma MicroRNA Profiles in HBeAg Positive and HBeAg Negative Children with Chronic Hepatitis B. PLoS One, 8: e58236.CrossRefPubMedPubMedCentralGoogle Scholar
  72. Wu G, Yu F, Xiao Z, Xu K, Xu J, Tang W, Wang J, Song E. 2011. Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro. Br J Cancer, 105: 146–153.CrossRefPubMedPubMedCentralGoogle Scholar
  73. Wu YL, Peng XE, Zhu YB, Yan XL, Chen WN, Lin X. 2015. Hepatitis B Virus X Protein Induces Hepatic Steatosis by Enhancing the Expression of Liver Fatty Acid Binding Protein. J Virol, 90: 1729–1740.CrossRefPubMedGoogle Scholar
  74. Xu Z, Zhai L, Yi T, Gao H, Fan F, Li Y, Wang Y, Li N, Xing X, Su N, Wu F, Chang L, Chen X, Dai E, Zhao C, Yang X, Cui C, Xu P. 2016. Hepatitis B virus X induces inflammation and cancer in mice liver through dysregulation of cytoskeletal remodeling and lipid metabolism. Oncotarget. doi: 10.18632/oncotarget.12372.Google Scholar
  75. Zhang GL, Li YX, Zheng SQ, Liu M, Li X, Tang H. 2010. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. Antiviral Res, 88: 169–175.CrossRefPubMedGoogle Scholar
  76. Zhang X, Hou J, Lu M. 2013. Regulation of hepatitis B virus replication by epigenetic mechanisms and microRNAs. Front Genet, 4: 202.CrossRefPubMedPubMedCentralGoogle Scholar
  77. Zhang X, Liu H, Xie Z, Deng W, Wu C, Qin B, Hou J, Lu M. 2016. Epigenetically regulated miR-449a enhances hepatitis B virus replication by targeting cAMP-responsive element binding protein 5 and modulating hepatocytes phenotype. Sci Rep, 6: 25389.CrossRefPubMedPubMedCentralGoogle Scholar
  78. Zhang X, Zhang E, Ma Z, Pei R, Jiang M, Schlaak JF, Roggendorf M, Lu M. 2011. Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1. Hepatology, 53: 1476–1485.CrossRefPubMedGoogle Scholar
  79. Zhong D, Huang G, Zhang Y, Zeng Y, Xu Z, Zhao Y, He X, He F. 2013a. MicroRNA-1 and microRNA-206 suppress LXRalphainduced lipogenesis in hepatocytes. Cell Signal, 25: 1429–1437.CrossRefPubMedGoogle Scholar
  80. Zhong D, Zhang Y, Zeng YJ, Gao M, Wu GZ, Hu CJ, Huang G, He FT. 2013b. MicroRNA-613 represses lipogenesis in HepG2 cells by downregulating LXRalpha. Lipids Health Dis, 12: 32.CrossRefPubMedPubMedCentralGoogle Scholar
  81. Zhu H, Shyh-Chang N, Segre AV, Shinoda G, Shah SP, Einhorn WS, Takeuchi A, Engreitz JM, Hagan JP, Kharas MG, Urbach A, Thornton JE, Triboulet R, Gregory RI, Altshuler D, Daley GQ. 2011. The Lin28/let-7 axis regulates glucose metabolism. Cell, 147: 81–94.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Wuhan Institute of Virology, CAS and Springer Science+Business Media Singapore 2016

Authors and Affiliations

  1. 1.College of Life ScienceShangrao Normal UniversityShangraoChina
  2. 2.Institute of VirologyUniversity Hospital of Essen, University of Duisburg-EssenEssenGermany

Personalised recommendations